# Nancy N. Navarro Gonzalez, M.D. – FDA Inspection, Sep 25, 2026

Source: https://www.keypedia.com/records/fda_inspections/nancy-n-navarro-gonzalez-md/fac7699a-4d40-4c36-a632-85fd1a4c8aca
Source feed: FDA_Inspections

> FDA inspection 1337510 of Nancy N. Navarro Gonzalez, M.D., September 25, 2026. 2 citations under 21 CFR part 312. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1337510
- Company Name: Nancy N. Navarro Gonzalez, M.D.
- Inspection Date: 2026-09-25
- Project Area: Bioresearch Monitoring
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Florida District Office
- Citation Count: 2

## Related Documents

- [FDA Inspection 1274379 - 2025-07-01](https://www.keypedia.com/records/fda_inspections/nancy-n-navarro-gonzalez-md/60ded2e4-9a41-415c-8792-89417ef6347c)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/chinyere-a-asanya/5d417b03-0ebb-4903-9626-3528d9d95536)

Company: https://www.keypedia.com/companies/nancy-n-navarro-gonzalez-md/42a440df-dab7-496e-a323-64e82b9fcb92

Office: https://www.keypedia.com/offices/florida-district-office/95b2a118-0b78-46e0-a54c-982bd7ce51c9